Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Foulke MC"'
Autor:
Smith CW; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Campos J; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Brown HC; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Jooss NJ; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.; Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands., Ivanova VS; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Harbi M; Pharmacology and Toxicology Department, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia., Garcia-Quintanilla L; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Jossi S; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Perez-Toledo M; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Rookes K; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Brill A; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Theodore LN; Sanofi, Cambridge, MA., Owens T; Sanofi, Cambridge, MA., LaStant J; Principia Biopharma, South San Francisco, CA., Foulke MC; Principia Biopharma, South San Francisco, CA., Mukai S; Sanofi, Cambridge, MA., Francesco M; Sanofi, Cambridge, MA., Storek M; Sanofi, Cambridge, MA., Hicks A; Sanofi, Cambridge, MA., Langrish C; Principia Biopharma, South San Francisco, CA., Nunn PA; Principia Biopharma, South San Francisco, CA., Cunningham AF; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Chauhan A; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Thomas MR; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Watson SP; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Nicolson PLR; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
Publikováno v:
Blood advances [Blood Adv] 2024 Nov 12; Vol. 8 (21), pp. 5557-5570.
Autor:
Xing Y; Principia Biopharma Inc., a Sanofi Company, South San Francisco, CA yan.xing@principiabio.com., Chu KA; Principia Biopharma Inc., a Sanofi Company, South San Francisco, CA., Wadhwa J; Principia Biopharma Inc., a Sanofi Company, South San Francisco, CA., Chen W; Principia Biopharma Inc., a Sanofi Company, South San Francisco, CA., Zhu J; Principia Biopharma Inc., a Sanofi Company, South San Francisco, CA., Bradshaw JM; Principia Biopharma Inc., a Sanofi Company, South San Francisco, CA., Shu J; Principia Biopharma Inc., a Sanofi Company, South San Francisco, CA., Foulke MC; Principia Biopharma Inc., a Sanofi Company, South San Francisco, CA., Loewenstein N; Principia Biopharma Inc., a Sanofi Company, South San Francisco, CA., Nunn P; Principia Biopharma Inc., a Sanofi Company, South San Francisco, CA., By K; Principia Biopharma Inc., a Sanofi Company, South San Francisco, CA., Phiasivongsa P; Principia Biopharma Inc., a Sanofi Company, South San Francisco, CA., Goldstein DM; Principia Biopharma Inc., a Sanofi Company, South San Francisco, CA., Langrish CL; Principia Biopharma Inc., a Sanofi Company, South San Francisco, CA.
Publikováno v:
ImmunoHorizons [Immunohorizons] 2021 Jul 29; Vol. 5 (7), pp. 581-589. Date of Electronic Publication: 2021 Jul 29.